This list is based on the watchlists of people on Stock Events who follow BXPHF. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Botanix Pharmaceuticals Limited operates as a commercial dermatology company in Australia and the United States. The company's lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used on the skin to treat underarm sweating in adults and children 9 years of age and older. Its product pipeline includes BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers; BTX 1801 for treating staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 for the treatment of papulopustular rosacea; and BTX 1204A for treating atopic dermatitis. The company was incorporated in 1984 and is based in West Perth, Australia.
Show more...
FAQ
What is Botanix Pharmaceuticals Limited stock price today?▼
The current price of BXPHF is $0.04 USD — it has increased by +15.94% in the past 24 hours. Watch Botanix Pharmaceuticals Limited stock price performance more closely on the chart.
What is Botanix Pharmaceuticals Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Botanix Pharmaceuticals Limited stocks are traded under the ticker BXPHF.
Is Botanix Pharmaceuticals Limited stock price growing?▼
BXPHF stock has risen by +15.94% compared to the previous week, the month change is a +0% rise, over the last year Botanix Pharmaceuticals Limited has showed a -81.82% decrease.
What is Botanix Pharmaceuticals Limited market cap?▼
Today Botanix Pharmaceuticals Limited has the market capitalization of 78.73M
When is the next Botanix Pharmaceuticals Limited earnings date?▼
Botanix Pharmaceuticals Limited is going to release the next earnings report on August 28, 2026.
What were Botanix Pharmaceuticals Limited earnings last quarter?▼
BXPHF earnings for the last quarter are -0.01 USD per share, whereas the estimation was -0.01 USD resulting in a -69% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Botanix Pharmaceuticals Limited revenue for the last year?▼
Botanix Pharmaceuticals Limited revenue for the last year amounts to 7.56M USD.
What is Botanix Pharmaceuticals Limited net income for the last year?▼
BXPHF net income for the last year is -112.43M USD.
Does Botanix Pharmaceuticals Limited pay dividends?▼
Yes, BXPHF dividends are paid annual. The last dividend per share was 60.77 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Botanix Pharmaceuticals Limited have?▼
As of April 05, 2026, the company has 11 employees.
In which sector is Botanix Pharmaceuticals Limited located?▼
Botanix Pharmaceuticals Limited operates in the Health Care sector.
When did Botanix Pharmaceuticals Limited complete a stock split?▼
The last stock split for Botanix Pharmaceuticals Limited was on June 16, 2016 with a ratio of 1000:3333.
Where is Botanix Pharmaceuticals Limited headquartered?▼
Botanix Pharmaceuticals Limited is headquartered in West Perth, AU.